Related Experiment Video
Updated: May 18, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Evaluation of a bayesian model integration-based method for censored data
Liping Hou1, Kai Wang, Christopher W Bartlett
1Battelle Center for Mathematical Medicine, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio 43205, USA.
Objective:
Non-random missing data can adversely affect family-based linkage detection through loss of power and possible introduction of bias depending on how censoring is modeled. We examined the statistical properties of a previously proposed quantitative trait threshold (QTT) model developed for when censored data can be reasonably inferred to be beyond an unknown threshold.
Methods:
The QTT model is a Bayesian model integration approach implemented in the PPL framework that requires neither specification of the threshold nor imputation of the missing data. This model was evaluated under a range of simulated data sets and compared to other methods with missing data imputed.
Results:
Across the simulated conditions, the addition of a threshold parameter did not change the PPL's properties relative to quantitative trait analysis on non-censored data except for a slight reduction in the average PPL as a reflection of the lowered information content due to censoring. This remained the case for non-normally distributed data and extreme sampling of pedigrees.
Conclusions:
Overall, the QTT model showed the smallest loss of linkage information relative to alternative approaches and therefore provides a unique analysis tool that obviates the need for ad hoc imputation of censored data in gene mapping studies.
Related Concept Videos
Censoring Survival Data
Kaplan-Meier Approach
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time until a...
Comparing the Survival Analysis of Two or More Groups
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

